Ribeiro, Bruna Felício Milazzotto Maldonado Porchia; Moreno, Ana Carolina Ramos; Ramos, Rodrigo Nalio; Diniz, Mariana de OLiveira; Andrade, Laís Helena Teixeira Merlin de; Rosa, Daniela S.; Barbuto, José Alexandre Marzagão 
; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Fonte: Molecular Cancer Therapeutics. Unidade: ICB
Assuntos: IMUNOLOGIA, MICROBIOLOGIA, PARASITOLOGIA, HERPES SIMPLES, PAPILLOMAVIRUS, VACINAS VIRAIS, NEOPLASIAS DO COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Bruna Felício Milazzotto Maldonado Porchia et al. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, v. 16, n. 9, p. 1922-1933, 2017Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-17-0071. Acesso em: 05 nov. 2024.APA
Ribeiro, B. F. M. M. P., Moreno, A. C. R., Ramos, R. N., Diniz, M. de O. L., Andrade, L. H. T. M. de, Rosa, D. S., et al. (2017). Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, 16( 9), 1922-1933. doi:10.1158/1535-7163.MCT-17-0071NLM
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071Vancouver
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071
